Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 92

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 92
---
 Investment closes. BLAC believes the PIPE Investment will close by February28, 2025, but there is no guarantee that the PIPE Investment close by such date or that it will ever close. If New OSR Holdings is unable to close the PIPE Investment or secure additional financing within a short period of time following the closing of the Business Combination, OSR Holdings could face claims from creditors that could cause voluntary or involuntary bankruptcy proceedings, in which case, the value of the stock and warrants of New OSR Holdings would likely be worthless. •The Sponsor and BLAC’s directors and officers have interests that are different from or that conflict with the interests of BLAC’s stockholders and that may have influenced their analysis of whether the Business Combination with OSR Holdings is appropriate as BLAC’s initial business combination. Such interests include that the Sponsor will lose its entire investment in BLAC if the Business Combination is not completed. •Following the consummation of the Business Combination, BLAC’s only significant asset will be its ownership of OSR Holdings, and such ownership may not be sufficient to pay its expenses or satisfy other financial obligations. •The level of due diligence conducted in connection with the Business Combination may not be as high as would be the case if OSR Holdings were to raise capital through an underwritten public offering, which could result in defects with OSR Holdings’ business or problems with OSR Holdings’ management to be overlooked. Risks Related to New OSR Holdings Securities •The price of New OSR Holdings’ Common Stock and warrants may be volatile. •Following the Business Combination, New OSR Holdings will be a controlled company within the meaning of the Nasdaq Listing Rules and, as a result, will qualify for, and may rely on, exemptions from certain corporate governance requirements. Stockholders of New OSR Holdings may not have the same protection afforded to stockholders of companies that are subject to such governance requirements. •An active, liquid trading market for New OSR Holdings Common Stock and warrants may not develop, which may limit your ability to sell New OSR Holdings Common Stock and warrants. •BLAC public stockholders who do not demand that BLAC redeem their public shares of BLAC Common Stock will experience immediate and material dilution upon closing of the Business Combination. Risks Related to OSR Holdings Business and Operations •OSR Holdings’ limited operating history, the early stage of its development programs and the inherent uncertainties and risks involved in pharmaceutical product development may make it difficult for it to execute on its business model. •OSR Holdings